Display options
Cite
Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(12):1-38
(2010). Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis. Ontario health technology assessment series, 10(12), 1-38.
"Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis." Ontario health technology assessment series vol. 10,12 (2010): 1-38.
Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(12):1-38. Epub 2010 Jun 01. PMID: 23074389; PMCID: PMC3377522.
Copy Download .nbib Format: NLM
Share it on

Ont Health Technol Assess Ser. 2010;10(12):1-38. Epub 2010 Jun 01.

Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis.

Ontario health technology assessment series

[No authors listed]

PMID: 23074389 PMCID: PMC3377522

Abstract

UNLABELLED: In July 2009, the Medical Advisory Secretariat (MAS) began work on Non-Invasive Cardiac Imaging Technologies for the Diagnosis of Coronary Artery Disease (CAD), an evidence-based review of the literature surrounding different cardiac imaging modalities to ensure that appropriate technologies are accessed by patients suspected of having CAD. This project came about when the Health Services Branch at the Ministry of Health and Long-Term Care asked MAS to provide an evidentiary platform on effectiveness and cost-effectiveness of non-invasive cardiac imaging modalities.After an initial review of the strategy and consultation with experts, MAS identified five key non-invasive cardiac imaging technologies for the diagnosis of CAD. Evidence-based analyses have been prepared for each of these five imaging modalities: cardiac magnetic resonance imaging, single photon emission computed tomography, 64-slice computed tomographic angiography, stress echocardiography, and stress echocardiography with contrast. For each technology, an economic analysis was also completed (where appropriate). A summary decision analytic model was then developed to encapsulate the data from each of these reports (available on the OHTAC and MAS website).The Non-Invasive Cardiac Imaging Technologies for the Diagnosis of Coronary Artery Disease series is made up of the following reports, which can be publicly accessed at the MAS website at: www.health.gov.on.ca/mas or at www.health.gov.on.ca/english/providers/program/mas/mas_about.htmlSINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY FOR THE DIAGNOSIS OF CORONARY ARTERY DISEASE: An Evidence-Based AnalysisSTRESS ECHOCARDIOGRAPHY FOR THE DIAGNOSIS OF CORONARY ARTERY DISEASE: An Evidence-Based AnalysisSTRESS ECHOCARDIOGRAPHY WITH CONTRAST FOR THE DIAGNOSIS OF CORONARY ARTERY DISEASE: An Evidence-Based Analysis64-Slice Computed Tomographic Angiography for the Diagnosis of Coronary Artery Disease: An Evidence-Based AnalysisCARDIAC MAGNETIC RESONANCE IMAGING FOR THE DIAGNOSIS OF CORONARY ARTERY DISEASE: An Evidence-Based AnalysisPease note that two related evidence-based analyses of non-invasive cardiac imaging technologies for the assessment of myocardial viability are also available on the MAS website:POSITRON EMISSION TOMOGRAPHY FOR THE ASSESSMENT OF MYOCARDIAL VIABILITY: An Evidence-Based AnalysisMAGNETIC RESONANCE IMAGING FOR THE ASSESSMENT OF MYOCARDIAL VIABILITY: an Evidence-Based AnalysisThe Toronto Health Economics and Technology Assessment Collaborative has also produced an associated economic report entitled:The Relative Cost-effectiveness of Five Non-invasive Cardiac Imaging Technologies for Diagnosing Coronary Artery Disease in Ontario [Internet]. Available from: http://theta.utoronto.ca/reports/?id=7 OBJECTIVE: The objective of this analysis was to determine the diagnostic accuracy of cardiac magnetic resonance imaging (MRI) for the diagnosis of patients with known/suspected coronary artery disease (CAD) compared to coronary angiography.

CARDIAC MRI: Stress cardiac MRI is a non-invasive, x-ray free imaging technique that takes approximately 30 to 45 minutes to complete and can be performed using to two different methods, a) perfusion imaging following a first pass of an intravenous bolus of gadolinium contrast, or b) wall motion imaging. Stress is induced pharmacologically with either dobutamine, dipyridamole, or adenosine, as physical exercise is difficult to perform within the magnet bore and often induces motion artifacts. Alternatives to stress cardiac perfusion MRI include stress single-photon emission computed tomography (SPECT) and stress echocardiography (ECHO). The advantage of cardiac MRI is that it does not pose the radiation burden associated with SPECT. During the same sitting, cardiac MRI can also assess left and right ventricular dimensions, viability, and cardiac mass. It may also mitigate the need for invasive diagnostic coronary angiography in patients with intermediate risk factors for CAD. EVIDENCE-BASED ANALYSIS:

LITERATURE SEARCH: A literature search was performed on October 9, 2009 using OVID MEDLINE, MEDLINE In-Process and Other Non-Indexed Citations, EMBASE, the Cumulative Index to Nursing & Allied Health Literature (CINAHL), the Cochrane Library, and the International Agency for Health Technology Assessment (INAHTA) for studies published from January 1, 2005 to October 9, 2008. Abstracts were reviewed by a single reviewer and, for those studies meeting the eligibility criteria, full-text articles were obtained. Reference lists were also examined for any relevant studies not identified through the search. Articles with unknown eligibility were reviewed with a second clinical epidemiologist and then a group of epidemiologists until consensus was established. The quality of evidence was assessed as high, moderate, low or very low according to GRADE methodology. Given the large amount of clinical heterogeneity of the articles meeting the inclusion criteria, as well as suggestions from an Expert Advisory Panel Meeting held on October 5, 2009, the inclusion criteria were revised to examine the effectiveness of cardiac MRI for the detection of CAD. Inclusion CriteriaExclusion CriteriaHeath technology assessments, systematic reviews, randomized controlled trials, observational studies≥20 adult patients enrolled.Published 2004-2009Licensed by Health CanadaFor diagnosis of CAD:Reference standard is coronary angiographySignificant CAD defined as ≥ 50% coronary stenosisPatients with suspected or known CADReported results by patient, not segmentNon-English studiesGrey literaturePlanar imagingMUGAPatients with recent MI (i.e., within 1 month)Patients with non-ischemic heart diseaseStudies done exclusively in special populations (e.g., women, diabetics)

OUTCOMES OF INTEREST: Sensitivity and specificityArea under the curve (AUC)Diagnostic odds ratio (DOR) SUMMARY OF FINDINGS: Stress cardiac MRI using perfusion analysis yielded a pooled sensitivity of 0.91 (95% CI: 0.89 to 0.92) and specificity of 0.79 (95% CI: 0.76 to 0.82) for the detection of CAD.Stress cardiac MRI using wall motion analysis yielded a pooled sensitivity of 0.81 (95% CI: 0.77 to 0.84) and specificity of 0.85 (95% CI: 0.81 to 0.89) for the detection of CAD.Based on DORs, there was no significant difference between pooled stress cardiac MRI using perfusion analysis and pooled stress cardiac MRI using wall motion analysis (P=0.26) for the detection of CAD.Pooled subgroup analysis of stress cardiac MRI using perfusion analysis showed no significant difference in the DORs between 1.5T and 3T MRI (P=0.72) for the detection of CAD.One study (N=60) was identified that examined stress cardiac MRI using wall motion analysis with a 3T MRI. The sensitivity and specificity of 3T MRI were 0.64 (95% CI: 0.44 to 0.81) and 1.00 (95% CI: 0.89 to 1.00), respectively, for the detection of CAD.The effectiveness of stress cardiac MRI for the detection of CAD in unstable patients with acute coronary syndrome was reported in only one study (N=35). Using perfusion analysis, the sensitivity and specificity were 0.72 (95% CI: 0.53 to 0.87) and 1.00 (95% CI: 0.54 to 1.00), respectively, for the detection of CAD.

ONTARIO HEALTH SYSTEM IMPACT ANALYSIS: According to an expert consultant, in Ontario: Stress first pass perfusion is currently performed in small numbers in London (London Health Sciences Centre) and Toronto (University Health Network at the Toronto General Hospital site and Sunnybrook Health Sciences Centre).Stress wall motion is only performed as part of research protocols and not very often.Cardiac MRI machines use 1.5T almost exclusively, with 3T used in research for first pass perfusion.On November 25 2009, the Cardiac Imaging Expert Advisory Panel met and made the following comments about stress cardiac MRI for perfusion analysis: Accessibility to cardiac MRI is limited and generally used to assess structural abnormalities. Most MRIs in Ontario are already in 24-hour, constant use and it would thus be difficult to add cardiac MRI for CAD diagnosis as an additional indication.The performance of cardiac MRI for the diagnosis of CAD can be technically challenging.

GRADE QUALITY OF EVIDENCE FOR CARDIAC MRI IN THE DIAGNOSIS OF CAD: The quality of the body of evidence was assessed according to the GRADE Working Group criteria for diagnostic tests. For perfusion analysis, the overall quality was determined to be low and for wall motion analysis the overall quality was very low.

References

  1. J Gen Intern Med. 2004 Dec;19(12):1181-91 - PubMed
  2. Can J Cardiol. 2007 Feb;23(2):107-19 - PubMed
  3. Eur Heart J. 2006 Oct;27(20):2448-58 - PubMed
  4. Rev Esp Cardiol. 2009 Apr;62(4):383-91 - PubMed
  5. Cardiovasc Ultrasound. 2008 May 29;6:21 - PubMed
  6. Am J Cardiol. 2008 Sep 15;102(6):649-52 - PubMed
  7. J Cardiovasc Magn Reson. 2008 Oct 17;10:45 - PubMed
  8. Circulation. 2003 Jan 7;107(1):149-58 - PubMed
  9. J Clin Epidemiol. 2006 Dec;59(12):1331-2; author reply 1332-3 - PubMed
  10. Heart Lung Circ. 2009 Jun;18(3):200-7 - PubMed
  11. Ont Health Technol Assess Ser. 2005;5(16):1-167 - PubMed
  12. Health Technol Assess. 2007 Dec;11(49):iii-iv, ix-115 - PubMed
  13. Ann Intern Med. 1999 May 4;130(9):719-28 - PubMed
  14. Ann Intern Med. 1999 May 4;130(9):709-18 - PubMed
  15. Health Technol Assess. 2004 Jul;8(30):iii-iv, 1-207 - PubMed
  16. Radiology. 2007 Dec;245(3):863-71 - PubMed
  17. Heart. 1999 Nov;82 Suppl 3:III16-21 - PubMed
  18. J Am Coll Cardiol. 2007 Oct 2;50(14):1343-53 - PubMed
  19. J Nucl Cardiol. 2002 Sep-Oct;9(5):515-22 - PubMed
  20. Int J Cardiol. 2007 May 16;118(1):88-96 - PubMed
  21. Heart. 2007 Nov;93(11):1381-5 - PubMed
  22. J Nucl Cardiol. 1997 Mar-Apr;4(2 Pt 2):S141-51 - PubMed
  23. Med Decis Making. 2007 Nov-Dec;27(6):772-88 - PubMed
  24. Circulation. 2007 Aug 14;116(7):e148-304 - PubMed
  25. BMJ. 2008 May 17;336(7653):1106-10 - PubMed
  26. AJR Am J Roentgenol. 2008 Aug;191(2):455-63 - PubMed
  27. J Am Soc Echocardiogr. 2003 Dec;16(12):1287-91 - PubMed
  28. Acad Emerg Med. 2008 Jul;15(7):623-32 - PubMed
  29. Heart. 2007 Nov;93(11):1363-8 - PubMed
  30. Eur Radiol. 2008 Feb;18(2):226-33 - PubMed
  31. J Am Coll Cardiol. 1999 Feb;33(2):453-62 - PubMed
  32. J Am Coll Cardiol. 2007 Jun 26;49(25):2440-9 - PubMed
  33. J Am Soc Echocardiogr. 2002 Nov;15(11):1335-45 - PubMed
  34. Am Heart J. 2007 Sep;154(3):510-8 - PubMed
  35. Chest. 2001 Jun;119(6):1791-800 - PubMed
  36. J Cardiovasc Magn Reson. 2008 Dec 18;10:59 - PubMed
  37. Am J Cardiol. 2002 Mar 15;89(6):711-8 - PubMed
  38. Radiology. 2008 Apr;247(1):57-63 - PubMed
  39. Eur Radiol. 2007 May;17(5):1301-9 - PubMed

Publication Types